Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_provenance.
- NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_assertion description "[The glucose-lowering effects of glucagon peptide antagonists and antiglucagon neutralising antibodies first demonstrated the potential of glucagon receptor (GCGR) antagonism as a treatment for hyperglycaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_provenance.
- NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_assertion evidence source_evidence_literature NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_provenance.
- NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_assertion SIO_000772 15948676 NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_provenance.
- NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_assertion wasDerivedFrom befree-20150227 NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_provenance.
- NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_assertion wasGeneratedBy ECO_0000203 NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP420448.RAPt0qQBq4VhyypO6VaGTr_WqUWS71-Sxu3w81jt5GvUU130_provenance.